PROPHASE LABS INC. - COMMON STOCK
0.5400
24-1月-25 16:45:00
15 分の遅延
株式
+0.0500
+10.20%
本日の幅
0.4430 - 0.5843
ISIN
N/A
ソース
NASDAQ
-
ProPhase Labs Announces Plans to Initiate Clinical Trial of Equivir (OTC)
22 2 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
16 2 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
15 2 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
06 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test
05 1 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
19 12 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
30 11 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Record Third Quarter 2022 Financial Results
10 11 2022 08:00:04 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute
08 11 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs to Present at Investor Summit Group’s Q4 Conference
07 11 2022 19:12:00 提供 Nasdaq GlobeNewswire
-
04 11 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Collaboration with G42 Healthcare
19 10 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
ProPhase Labs to Present at The ThinkEquity Conference
18 10 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.
17 10 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
06 9 2022 08:15:00 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Record Second Quarter 2022 Financial Results
11 8 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
04 8 2022 20:33:00 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces New $6 Million Stock Repurchase Plan
26 7 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 7 2022 18:00:00 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Licensing of New Investigational Cancer Compounds
21 7 2022 08:30:00 提供 Nasdaq GlobeNewswire